The term MGC99813 appears to be a gene identifier, potentially from a gene catalog or a specific designation used within a genomic database. Genes in such catalogs are often named with an accession-like format when initially sequenced and before their functions or products are fully characterized. If MGC99813 is indeed a gene, its associated protein product would be the focus for any potential activators. These activators, were they to exist, would be molecules designed to enhance or modulate the activity of the protein encoded by the MGC99813 gene. The mode of action of these activators would depend on the functional domains of the protein and could involve increasing its stability, altering its conformation, or facilitating its interaction with other cellular components or substrates.
In the scenario where MGC99813 Activators were a defined chemical class, a detailed description would include the molecular characteristics that enable specific interaction with the MGC99813 protein. Activators might bind to regions of the protein essential for its activity, potentially inducing a conformational change that results in an increased activity or prevents the protein from being inhibited. The activators might also mimic or enhance the effect of naturally occurring ligands or substrates. Research into such activators would utilize a battery of structural and biochemical techniques to understand the precise nature of the interaction. Techniques like cryo-electron microscopy or X-ray crystallography could be employed to determine the structure of the protein both with and without the activator bound, revealing the binding site and the induced changes in protein structure. Biophysical methods such as surface plasmon resonance or isothermal titration calorimetry would be used to study the binding kinetics and affinity between the protein and the activators. However, in the absence of established research or recognition of MGC99813 Activators in the scientific community, any detailed description of such a class of chemicals remains speculative.
VER TAMBIÉN ....
Items 1 to 10 of 11 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
La tunicamicina induce un estrés de RE que puede conducir a la activación de la respuesta a proteínas no plegadas, afectando potencialmente a la transcripción de varias proteínas transmembrana. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
El Thapsigargin altera la homeostasis del calcio en el RE, provocando estrés en el RE y posiblemente potenciando la expresión de ciertas proteínas transmembrana en respuesta. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
La brefeldina A interfiere en la función del aparato de Golgi, lo que puede desencadenar una respuesta celular que afecte a la expresión de proteínas transmembrana. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
El ácido retinoico actúa a través de sus receptores para modular la transcripción de genes, lo que podría afectar a la expresión de proteínas transmembrana como la TMEM198. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Al aumentar los niveles de AMPc, la forskolina puede activar la PKA e influir así en la regulación transcripcional de los genes que codifican proteínas transmembrana. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
Como análogo de la glucosa, la 2-Deoxi-D-glucosa induce estrés metabólico, lo que podría alterar el perfil de expresión de las proteínas transmembrana. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
El MG-132 es un inhibidor del proteasoma que puede provocar la acumulación de proteínas mal plegadas, aumentando potencialmente la expresión de proteínas implicadas en la proteostasis, incluidas las proteínas transmembrana. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $63.00 $173.00 | 7 | |
El cloruro de cobalto es un agente mimético de la hipoxia que puede estabilizar HIF-1α, lo que conduce a la activación transcripcional de genes sensibles a la hipoxia, que pueden incluir proteínas transmembrana. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
La curcumina puede modular varias vías de señalización y afectar a los factores de transcripción, alterando potencialmente la expresión de proteínas transmembrana. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
El EGCG es un polifenol que puede influir en varias vías celulares y puede modular la expresión de genes que codifican proteínas transmembrana. | ||||||